 |
We Recommend Novel by Kim Green on Experiencing Lupus |
 |
International Study Funded in Part by LRI Uncovers Three Genes Associated with Lupus |
Visit LupusTrials.org to learn about a new clinical trial looking at an investigational treatment for men and women with systemic lupus erythrematosus.
On March 9, 2011, the U.S. Food and Drug Administration approved BENLYSTA® (belimumab) for adults with active systemic lupus, which means we have the first new treatment approved for this chronic autoimmune disease in more than half a century!
“This is a major breakthrough in the care and treatment of lupus, and one that I have been waiting for, for 30 years," said Lupus LA Founder Daniel J. Wallace, MD, a clinical professor of medicine at the University of California, Los Angeles.
How Los Angeles Moved the New Treatment Forward »
What is Benlysta—and Who is it for?
Learn about Benlysta in our Q&A with Dr. Dan Wallace »
Lupus Research Institute Hails Landmark Achievement
Read our national research partner's response to the historic news »
 |
 |
 |
Lupus, My Doctor, and Me |
 |
My Turn / Lupus LA Members Speak Out Health Has a History by Barbara De Witt |
 |
The Lupus Sisterhood by Renee Rinaldi, MD |
